Optimal Length of Pre-inserted ETT for Nasal Fiber Optic Intubation
NCT ID: NCT02016144
Last Updated: 2013-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2012-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation on the Proper Size of the Nasotracheal Tube and Depth in Nasotracheal Intubation: a Preliminary Study
NCT02876913
Learning Curve of Fiberoptic Intubation Through Supraglottic Airway Device
NCT04482166
The Ideal Length of the Nasotracheal Tube Considering Nasotracheal Tube Size
NCT03282604
Determining the Depth of Endotracheal Tube Insertion
NCT02158247
Optimal Insertion Depth of FOB for Oral FOB Intubation
NCT05277064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 20-65 yr (adults)
Exclusion Criteria
* bleeding diatheses
* requirement of awake intubation
* a previous major oral and maxillofacial surgery history
* anatomical deformity of the face, neck and upper airway
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Dental Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung-Man Lee
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jung-Man Lee, M.D
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Dental Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Dental Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JLee_optimal_length
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.